Despite advances in care, cardiovascular diseases remain the leading cause of death
worldwide. As a result, identifying suitable biomarkers for early diagnosis and improving …

Mitochondrion is a multifunctional organelle in a cell, and it is one of the important targets of
antitumor therapy. Conventional mitochondrial targeting strategies can hardly distinguish the …

Drug therapy for vascular disease has been promoted to inhibit angiogenesis in
atherosclerotic plaques and prevent restenosis following surgical intervention. This paper …

Myocardial ischemia/reperfusion (MI/R) injury is the primary cause of postischemic heart
failure. The increased expression of Thioredoxin-interacting protein (TXNIP) has been …

Calorie restriction (CR) and fasting affect lifespan, disease susceptibility and response to
acute injury across multiple animal models, including ischaemic injuries such as myocardial …

This study presents preliminary computational and experimental findings on two alternative
permanent magnet configurations helpful for magnetic drug administration in vivo. A …

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …

Based on our prior research, we synthesized iron-oxide nanoparticles (IONPs) in two
shapes (spherical and cubic) and sized them for the current inquiry. This research examined …

Triple-negative breast Cancer (TNBC) is one of the deadliest types, making up about 20% of
all breast cancers. Chemotherapy is the traditional manner of progressed TNBC treatment; …

Myocardial infarction (MI) and its associated poor prognosis pose significant risks to human
health. Nanomaterials hold great potential for the treatment of MI due to their targeted and …